You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

NEW YORK, July 7, 2020 /PRNewswire/ --Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Rexahn Pharmaceuticals, Inc. ("Rexahn" or the "Company") (NYSE:REXN)relating toits combination with Ocuphire Pharma, Inc. Under the terms of the agreement, Rexahn will issue 4.6979 shares of Rexahn commonstock to Ocuphire shareholders for each share of Ocuphire common stock owned. The investigation focuses on whether Rexahn Pharmaceuticals, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company. Click here for more information:https://www.monteverdelaw.com/case/rexahn-pharmaceuticals-inc. It is free and there is no cost or obligation to you. About Monteverde & Associates PC We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases. If you own common stock in Rexahn Pharmaceuticals, Inc. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [emailprotected] or by telephone at (212) 971-1341. Contact:Juan E. Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building350 Fifth Ave. Suite 4405New York, NY 10118United States of America[emailprotected]Tel: (212) 971-1341 Cell: (646) 522-4840 Attorney Advertising. (C) 2020 Monteverde & Associates PC.The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC Related Links http://www.monteverdelaw.com

Answer: INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Rexahn Pharmaceuticals, Inc.- REXN